Viswanadhan Krishnan — SEC Form 4 filings
SEC reporting owner CIK 1999913. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-06 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 5,918 shares, $184,967 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 2,959 shares @ $34.71 ($102,707) in AGIOS PHARMACEUTICALS, INC., filed 2026-04-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Strategy and Operations | 5 | — | 2 legs · 5,918 sh · $184,967 | 10 |
| CARGO Therapeutics, Inc. (CRGX) | Director | 3 | — | — | 4 |
Form 4 filings — Viswanadhan Krishnan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,000 (derivative) @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 8,100 @ $0 · Sale (S): 2,959 @ $34.71 · Option exercise (M): 8,100 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 8,100 @ $0 · Sale (S): 2,959 @ $27.80 · Option exercise (M): 8,100 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | CARGO Therapeutics, Inc. (CRGX) | Disposition to issuer (D): 3,173 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2025-06-23 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/award (A): 24,300 (derivative) @ $0 · Grant/award (A): 55,374 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 23,742 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1999913 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →